Skip to main content
Top

Drugs

Issue 8/2019

Content (10 Articles)

Drugs in Development for Acute Kidney Injury

Matthew Hulse, Mitchell H. Rosner

Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer

Sally C. M. Lau, Ullas Batra, Tony S. K. Mok, Herbert H. Loong

Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?

  • Original Research Article

Aurelie Lenglet, Nicolas Fabresse, Méline Taupin, Cathy Gomila, Sophie Liabeuf, Said Kamel, Jean Claude Alvarez, Tilman B. Drueke, Ziad A. Massy

Peficitinib: First Global Approval

Anthony Markham, Susan J. Keam

Risankizumab: First Global Approval

Kate McKeage, Sean Duggan

Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia

Young-A. Heo, Yahiya Y. Syed, Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images